CJC 1295 NO DAC (5mg Vial) Dosage Protocol

CJC 1295 NO DAC (5mg Vial) Dosage Protocol

Quickstart Highlights

CJC 1295 NO DAC (5mg) dosage protocol typically involves daily or twice-daily injections, leveraging its shorter half-life compared to the DAC version.

  • Often administered 1–3 times per day for optimal GH release
  • Typical dose range: 100–300 mcg per injection
  • Reconstitute to achieve accurate measurements on an insulin syringe
  • Store lyophilized in the freezer; reconstituted in the refrigerator
CJC 1295 NO DAC Vial

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily injection protocols

Standard / Gradual Approach (3 mL = ~1,666 mcg/mL)

Week Daily Dose (mcg) Units (per injection) Times per Day
Weeks 1–4 100 mcg ~6 units 2x daily
Weeks 5–8 150 mcg ~9 units 2x daily

Reconstitute with 3 mL of bacteriostatic water, yielding ~1,666 mcg per mL. Each “10 units” on a 100-unit insulin syringe corresponds to ~166 mcg. Note that 100 mcg is about 6 units—slightly below 10 units; consider using 50-unit or 30-unit syringes for easier measurement.

  1. Draw 3.0 mL of bacteriostatic water into a sterile syringe.
  2. Inject the water slowly along the vial wall to reduce foaming.
  3. Gently swirl—avoid vigorous shaking—to fully dissolve the peptide.
  4. Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.

Advanced / Aggressive Approach (3 mL = ~1,666 mcg/mL)

Week Daily Dose (mcg) Units (per injection) Times per Day
Weeks 1–4 200 mcg ~12 units 2x daily
Weeks 5–8 300 mcg ~18 units 2x daily

For higher daily doses (200–300 mcg), continue using 3 mL of bacteriostatic water. If each injection exceeds ~25–30 units, you may split into two smaller injections to maintain accuracy.

  1. Draw 3.0 mL of bacteriostatic water into a sterile syringe.
  2. Slowly inject the water along the vial wall to minimize foam.
  3. Gently roll or swirl the vial—no vigorous shaking.
  4. Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.

Note: This guide is for educational purposes only. Always consult with a qualified healthcare professional.

Protocol Overview

A concise summary of this multiple-daily dosing regimen.

  • Goal: Pulsatile stimulation of GH via more frequent daily injections
  • Schedule: 1–3 injections per day, typically for 8–12 weeks
  • Dose Range: 100–300 mcg per injection (may vary with research goals)
  • Reconstitution: ~3 ml for accurate dosing (≥6 units per 100 mcg)
  • Storage: Keep lyophilized vials frozen; refrigerate after mixing

Dosing Protocol

Suggested split dosing for consistent GH pulses.

  • Daily Dose: Start at ~100 mcg per injection; adjust gradually
  • Frequency: 2 daily injections (morning & evening) or per research needs
  • Cycle Length: 8–12 weeks (longer cycles may require multiple vials)
  • Maximum Dose: Some protocols explore up to 300 mcg per injection, 2–3x daily
  • Timing: Commonly administered on empty stomach; 2+ hours after a meal

Storage Instructions

Proper storage protects peptide integrity.

  • Lyophilized: Freeze or refrigerate (−20°C or 2–8°C) until mixing
  • Reconstituted: Refrigerate at 2–8°C
  • Use within 30 days of mixing
  • Avoid repeated freeze-thaw events

Supplies Needed

Gather these items for an 8–12 week research cycle.

  • Peptide Vials:
    • 8 wks at moderate doses ≈ 1–2 vials
    • 12 wks at moderate doses ≈ 2+ vials
    High-dose protocols may need more
  • Insulin Syringes:
    • 8 wks ≈ 16–24 syringes (2/day)
    • 12 wks ≈ 24–36 syringes
  • Bacteriostatic Water: 1× 30 ml recommended
  • Alcohol Swabs: 1 box to ensure sterile practice

Important Notes

Practical tips to ensure a smooth research process.

  • Use sterile technique; always swap needles or syringes for each injection.
  • Keep injection times consistent daily to maintain stable GH pulses.
  • Monitor for any adverse responses; consult a professional if issues arise.
  • Document each injection and adjust protocol only as justified by research findings.

How This Works

CJC 1295 NO DAC is a short-acting GHRH analog that stimulates growth hormone release.

  • Half-Life: Shorter than DAC variant; used more frequently for GH pulses
  • GH Release: Encourages the pituitary to secrete GH in a pulsatile manner
  • Research Potential: Exploring effects on recovery, lean mass, and metabolism

Potential Benefits & Side Effects

Observations vary; these points are reported anecdotally and in research contexts.

  • Improved muscle recovery and possible support for lean mass
  • May assist with fat metabolism when combined with diet/exercise
  • Occasional side effects: redness at injection site, flushing, mild headache
  • Less common issues: joint stiffness, water retention, or short-term fatigue

Lifestyle Factors

Complementary strategies to maximize research outcomes.

  • Consume a balanced diet rich in protein to support muscle studies
  • Maintain regular exercise and adequate sleep for consistent GH response
  • Manage stress levels to avoid cortisol-related suppression of GH release

Injection Technique

Simple guidelines for safe daily injections.

  • Clean vial rubber stopper & injection site with alcohol swabs
  • Insert needle at a 45–90° angle into subcutaneous tissue
  • Inject slowly & rotate sites (abdomen, thigh, etc.)

Important Note

This guide is for educational purposes only. Always consult a qualified healthcare provider before starting or modifying any therapy.

References


  • FDA Document
    – Government attachment on peptide regulation

  • LJMU Research
    – Netnography study of female CJC-1295 usage

  • PubMed
    – GH pulsation study with CJC-1295

  • PubMed
    – Investigates GH and IGF-1 synergy

  • PubMed
    – Clinical trial data on CJC-1295

  • U Maryland Archive
    – Repository record on GH peptides

  • JCEM (OUP)
    – GH deficiency therapy insights

  • Touch Endocrinology
    – Pediatric GH deficiency treatment article